You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
永安藥業(002365.SZ):美國專利商標局的相關裁定將對公司新澤西地方法院的專利訴訟事項產生積極影響
格隆匯 04-06 17:43

格隆匯4月6日丨永安藥業(002365.SZ)公佈,美國公司VitaworksIP,LLC向新澤西地方法院起訴公司牛磺酸產品涉嫌侵犯其專利權。公司聘請了美國的律師事務所應訴,協助公司向新澤西法院提交相關文件資料,並針對Vitaworks起訴書中的諸多漏洞於2016年12月23日向新澤西法院提出了駁回申請,同期也收到了由湖北省漢江中級人民法院送達的國際訴訟相關文書。上述內容公司分別於2016年9月10日及2017年12月27日發佈《關於涉及訴訟的公告》、《關於訴訟事項的進展公告》進行了披露。

近日,公司獲悉,美國專利商標局就涉訴專利進行了兩項裁定,一是同意專利持有人VitaworksIP,LLC撤銷“專利451”和撤銷“專利890”相關的第1項和第3-10項權利要求;二是裁定“專利450”相關的第1項和第3-7項權利要求無效。

針對上述事項,公司律師認為美國專利商標局的相關裁定將對公司新澤西地方法院的專利訴訟事項產生積極影響。下一步,公司將加強與美國律師的交流,加快推動新澤西地方法院訴訟事項的進程。

環氧乙烷法生產牛磺酸是公司自主研發並得到工業應用的工藝,公司一直致力於牛磺酸生產工藝的持續研發和更新,同時大力加強相關知識產權的保護,保持生產工藝的先進性和增強公司核心競爭力。有關專利訴訟的重要進展,公司將在獲得信息後及時予以披露。敬請廣大投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account